Latest Rheumatology News
Guidance Issued for Osteoporosis Management During COVID-19
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Most Physicians Have Seen False-Negative COVID-19 Test Results
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Guidance Issued for Osteoporosis Management During COVID-19
posted May 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
In a joint guidance document issued by the American Society for Bone and Mineral Research, American Association of Clinical Endocrinologists, Endocrine Society, European Calcified Tissue Society, and National Osteoporosis Foundation, recommendations are presented for the management of osteoporosis during the COVID-19 pandemic.
Editor's Recommendations
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Consensus Statement Addresses Management of Skeletal Fragility in Patients With CKD 
Skipping Breakfast, Eating Late May Increase Osteoporosis Risk Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder Rheumatology Conference Highlights
Rheumatology Monthly Briefings
Rheumatology Conference News
Stay Connected
